Apoptosis induction by a novel retinoid-related molecule requires nuclear factor-κB activation

Cancer Research

Volumn 65, Issue 11, 2005, Pages 4909-4917

  Farhana, Lulu ^a,b   Dawson, Marcia I ^c   Fontana, Joseph A ^a,d  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BURNHAM INSTITUTE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 3 CHLOROCINNAMIC ACID; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FAS ANTIGEN; GELDANAMYCIN; HEAT SHOCK PROTEIN 90; HELENALIN; I KAPPA B ALPHA; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL XL; RETINOID; SYNAPTOTAGMIN; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3T3 CELLS; ADAMANTANE; ANIMALS; ANTIGENS, CD95; APOPTOSIS; BCL-X PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CINNAMATES; HUMANS; I-KAPPA B PROTEINS; MALE; MICE; NF-KAPPA B; PROSTATIC NEOPLASMS; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 19644366033     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-4124     Document Type: Article

References (67)

1. Chen FE, Gosh G. Regulation of DNA binding by Rel/ NF-κB transcription factors - structural views. Oncogene 1999;18:6845-52.
2. Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 1999;18:6853-66.
3. Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark G. Distinct roles of the IκB kinase α and β subunits in liberating nuclear factor (NF-κB) from IκB and in phosphorylating the p65 subunit of NF-κB. J Biol Chem 2002;277:3863-9.
4. Lin B, Williams-Skipp C, Tao Y, et al. NF-κ B functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Differ 1999;6:570-82.
5. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the Rel A component of NF-κB. Nature 1995;376:167-70.
6. Begg AA, Baltimore D. An essential role for NF-κB in preventing TNF-α induced cell death, Science 1996;274;782-4.
7. Van Antwerd DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-α induced apoptosis by NF-κB. Science 1996;274:787-9.
8. Liv ZG, Hsu H, Gorddel DV, Karin M. Dissection of the TNF receptor I effector functions. JNK activation in not linked to apoptosis while NF-κB activation prevents cell death. Cell 1996;87:565-76.
9. Wang CY, Mayo MW, Baldwin Jr AS. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 1996;274:784-7.
10. Abbadie C, Kabrun N, Bouali F, et al. High levels of c-Rel expression are associated with programmed cell death in developing avian embryo and in bone marrow cells in vitro. Cell 1993;75:889-912.
11. Kitajima L, Soejima Y, Takajaki L, Beppu H, Tokioka T, Muruyama I. Ceremide-induced nuclear translocation of NF-κB is a potential mediator of the apoptotic response in murine clonal osteoblasts. Bone 1996;19:263-70.
12. Hunot S, Brugg B, Richard D, et al. Nuclear translocation of NF-κB is increased in dopamineagic neurons of patients with Parkinson disease. Proc Natl Acad Sci USA 1997;94:7531-6.
13. Lin K-I, Lee S-H, Narayanan R, Baraban JM, Hardwick JM, Ratan RR. Thiol agents and Bcl-2 identify an α virus-induced apoptotic pathway that requires activation of the transcription factor NF-κB. J Cell Biol 1995;131:1179-81.
14. Marianneau P, Cardon A, Edelman L, Devbel V, Despres P. Dengue virus replication in human hepatoma cell activates NF-κB which in turn induces apoptotic cell death. J Virol 1997;71:3244-9.
15. Watanbe K-I, Kubota M, Hamahata K, Lin Y-W, Usami I. Prevention of episode-induced apoptosis by proteasome inhibitors in a human leukemia cell line but not in fresh acute leukemia blasts. Biochem Pharmacol 2000;60:823-30.
16. Chen X, Kandasamy K, Srivastava L. Differential effect of Rel A (p65) and c-Rel subunits on nuclear factor KB in tumor necrosis factor related apoptosis-inducing ligand signaling. Cancer Res 2003;63:1059-66.
17. Ravi R. Bedi GC, Engstrom LW, et al. Regulation of death receptor expression and Trail/Apo2L-induced apoptosis by NF-κB. Nat Cell Biol 2001;3:409-16.
18. Ouaaz F, Li M, Beg AA. A critical role for the RelA of nuclear factor κB in regulation of multiple immune-response genes and in Fas-induced cell death. J Exp Med 1999;189:999-1004.
19. Levkau B, Scatena M, Giachelli CM, Ross R, Raines EW. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop. Nat Cell Biol 1999;1:227-33.
20. Zhang Y, Dawson MI, Ning Y, et al. Induction of apoptosrs in retinoid refractory AML by a novel AHPN analog. Blood 2003;102:3743-52.
21. Zhang Y, Dawson MI, Mohammad R. et al. Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its non-retinoidal analog. Blood 2002;100:2917-25.
22. Farhana L, Dawson MI, Huang Y, et al. Apoptosis signaling by the novel retinoid 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidyl inositol 3-kinase and AKT activities. Oncogene 2004;23:1874-84.
23. Zhang Y, Rishi AK, Dawson MI, et al. S-phase arrest and apoptosis induced in normal mammary epithelial cells by a novel retinoid. Cancer Res 2000;60:2025-32.
24. Farhana L, Dawson M, Rishi AK, et al. Cyclin B and E2F-1 expression in prostate carcinoma cells treated with the novel retinoid DC437 are regulated by the ubiquitin-mediated pathway. Cancer Res 2002;62:3842-9.
25. Hoffmann A, Leuchenko A, Scott ML, Baltimore D. The IκB-NF-κB signaling module: temporal control and selective gene activation. Science 2002;298:1241-5.
26. Manning A, Rao A. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 1997;278:860-6.
27. DiDonato J, Mercuric F, Rosette C, et al. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol 1996;16:1295-304.
28. Gosh S, Karin M. Missing pieces in the NF-κB puzzle. Cell 2002;109:581-96.
29. Muenchen HJ, Lin D-L, Walsh MA, Keller ET, Pienta KJ. Tumor necrosis Factor-α-induced apoptosis in prostate cancer cells through inhibition of nuclear factor-κB by an IκBα "Super Repressor." Clin Cancer Res 2000;6:1969-77.
30. Hellarbrand C, Jobin C, Limuro Y, Licato L, Balfour Sartor R, Brenner DA. Inhibitions of NFκB in activated rat hepatic stellate cells by proteasome inhibitors and an IκB super-repressor. Hepatology 1998;27:1285-95.
31. Li N, Karin M. Ionizing Radiation and shortwave UV activate NF-κB through two mechanisms. Proc Natl Acad Sci USA 1998;95:13012-7.
32. Chen ZJ, Hagler J. Palombella VJ, et al. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev 1995;9:1586-97.
33. Whitesell L, Mimmaugh EG, De Costa B, Myers CE, Neckers LM. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role stress proteins in oncogenic transformation. Proc Natl Acad Sci USA 1994;91:8324-8.
34. Broemer M. Krappman D, Scheidereit C. Requirement of Hsp90 activity for Iκ kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation. Oncogene 2004;23:5378-86.
35. Byrd CA, Bornmann W, Erdjument-Bromage H, et al. Heat shock protein 90 mediates macrophage activation by taxol bacterial lipopolycaaharide. Proc Natl Acad Sci USA 1999;96:5645-50.
36. Chakravortty D, Kato Y, Sugiyama T, et al. The inhibitory action of sodium arsenite on lipopolysaccharide induced nitric oxide formation in RAW 267.4 macrophage cells: role of Raf 1 in lipopolysaccaride signaling. J Immunol 2001;166:2011-7.
37. Sugita T, Tanaka S, Murakami T, Miyoshi H, Ohnuki T. Immunosuppressive effects of heat shock protein 90-binding antibiotic geldanamycin. Biochem Mol Biol Int 1999;47:587-95.
38. Lynss G, Knorre A, Schindt TJ, Pahl HL, Merfort I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly inhibiting p65. J Biol Chem 1998;273:33508-16.
39. Wang C-Y, Mayo MW, Korneluk RG, Goeddel DV, Baldwin Jr AS. NF-κB anti apoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998;281:1680-3.
40. Bargou RC, Emmerich F, Krappmann D, et al. Constitutive nuclear factor-κB-Rel A activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997;100:2961-9.
41. Turco MC, Romano MF, Petrella A, Bisogni R, Tassone P, Venuta S. NF-κB/Rel A mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors. Leukemia 2004;18: 11-7.
42. Pajonk F, Pajonk K, McBride W. Inhibition of NF-κB, clonogenicity and radiosensitivity of human cancer. J Natl Cancer Inst 1999;91:1956-60.
43. Van Hogerlindin M, Rozell B. Ahrlund Richter L. Toftigard R. Squamous cell carcinomas and induced apoptosis in skin with inhibited Rel/nuclear factor-κB signaling. Cancer Res 1999;59:3299-303.
44. Van Antwerp DI, Martin SI, Kafri T, Green DR. Verma IM. Suppression of TNF α-induced apoptosis 67 NF-κB. Science 1996;274:787-9.
45. Karin M, Lin A. NF-κB at the crossroads of life and death. Nature Immunology 2002;3:221-7.
46. Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998;17:2215-23.
47. Shu HB, Takeuchi M, Goeddel DV. The TNF2 signal transducers TRAF2 and c-IAP1 are components of the TNF1 signaling complex Proc Natl Acad Sci USA 1996;93:13973-8.
48. Liston P, Roy N, Tamai K, et al. Suppression of apoptosis in mammalian cells and a related family of IAP genes. Nature 1996;379:349-53.
49. Takahashi R, Deveraux Q, Welsh K, Assa-Munt N, Selvesen GS, Reed JC. A single Bir domain of XIAP sufficient for inhibiting caspases. J Biol Chem 1998;273:7781-90.
50. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J 1999;18:5242-51.
51. Panet H, Barzakai A, Daily D, Melamed E, Offen D. Activation of nuclear transcription factor KB (NF-κB) is essential for dopamine-induced apoptosis in PC12 cells. J Neurochem 2001;77:291-8.
52. Muller I, Pfister M, Grohs V, et al. Receptor activator of nuclear factor KB ligand plays a non-redundant role in doxorubicin-induced apoptosis. Cancer Res 2003;63:1772-5.
53. Huang Y, Fang Y, Wu J, et al. Regulation of Vinca-alkaloid-induced apoptosis by NF-κB/IκB pathway in human tumor cells. Mol Cancer Ther 2004;3:271-7.
54. Matsui K, Fine A, Zhu B, Marsak-Rothstein A, Ju S-T. Identification of two NF-κB sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J Immunol 1998;161:3469-73.
55. Ryan KM, Ernst MK, Rice MR, Vousden KH. Role of NF-κB in p53-mediated programmed cell death. Nature 2000;404:892-7.
56. Lee H, Arsura M, Wu M, Duyao M, Buckler AJ, Sonenshein GE. Role of rel-related factors in control of C-Myc gene transcription in receptor-mediated apoptosis of the murine B cell WEH1 231 line. J Exp Med 1995;181:1169-77.
57. Sun S-Y, Yue P, Lotan R. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate cells. Oncogene 2000;19:4513-22.
58. Mercurio F, Zhu H, Murray BW, et al. IKK-1 and IKK-2 cytokine activated IKK kinases essential for NF-κB activation. Science 1997;278:860-8.
59. Woronicz JD, Gao X, Cato X, Rothe M, Goeddel DV. IκB kinase-α and NIK. Science 1997;276:866-9.
60. Zandi E, Rothwarf DM, Delhase M, Hayanawa M, Karian M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ necessary for IκB phosphorylation of NF-κB activation. Cell 1997;91:243-52.
61. Miller BS, Zandi E. Complete reconstitution of human IκB kinase (IKK) complex in yeast. Assessment of its stoichiometry and the role of IKKα on the complex activity in the absence of stimulation. J Biol Chem 2001;276:36320-6.
62. Rothwarf DM, Karian M. The NF-κB activation pathway: a paradigm information transfer from membrane to nucleus. Science's STKE http://www.org/cg/content/full/OC.sigtrans; 1999/s/ref.
63. Bayon Y, Oritz MA, Lopez-Hernandez FJ. Inhibition of IκB kinase by a new class of retinoid-related anticancer agents that induce apoptosis. Mol Cell Biol 2003;23:1061-77.
64. Pfahl M, Piedrafita FJ. Retinoid targets for apoptosis induction. Oncogene 2003;22:9058-62.
65. Dawson MI, Harris DL, Liu G, et al. Antagonist analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-carboxylic acid (AHPN) family of apoptosis inducers that effectively blocks AHPN-induced apoptosis but not cell cycle arrest. J Med Chem 2004;47:3518-36.
66. Li Y, Lin B, Agadir A, Liu R, et al. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 2000;289:1159-64.
67. Lin B, Kolluri SK, Lin F, et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear receptor Nur77/TR3. Cell 2004;116:27-40.